190
Views
0
CrossRef citations to date
0
Altmetric
Research Reports

Genetic factors for idiopathic choroidal neovascularization

, , , , &
Pages 309-312 | Received 27 Dec 2018, Accepted 02 Jun 2019, Published online: 12 Sep 2019

References

  • Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103(8):1241–44.
  • Ho AC, Yannuzzi LA, Pisicano K, DeRosa J. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology. 1995;102(5):782–89. doi:10.1016/S0161-6420(95)30968-2.
  • Lindblom B, Andersson T. The prognosis of idiopathic choroidal neovascularization in persons younger than 50 years of age. Ophthalmology. 1998;105(10):1816–20. doi:10.1016/S0161-6420(98)91021-1.
  • Giovannini A, Neri P, Mercanti L, Brue C. Photodynamic treatment versus photodynamic treatment associated with systemic steroids for idiopathic choroidal neovascularisation. Br J Ophthalmol. 2007;91(5):620–23. doi:10.1136/bjo.2006.103135.
  • Chan WM, Lai TY, Lau TT, Lee VY, Liu DT, Lam DS. Combined photodynamic therapy and intravitreal triamcinolone for choroidal neovascularization secondary to punctate inner choroidopathy or of idiopathic origin: one-year results of a prospective series. Retina. 2008;28(1):71–80. doi:10.1097/IAE.0b013e31815e9339.
  • Machida S, Fujiwara T, Murai K, Kubo M, Kurosaka D. Idiopathic choroidal neovascularization as an early manifestation of inflammatory chorioretinal diseases. Retina. 2008;28(5):703–10. doi:10.1097/IAE.0b013e318160798f.
  • Machida S, Hasegawa Y, Kondo M, Fujiwara T, Asano T, Murai K, Tazawa Y. High prevalence of myopia in Japanese patients with idiopathic focal subretinal neovascularization. Retina. 2006;26(2):170–75. doi:10.1097/00006982-200602000-00008.
  • Rivera A, Fisher SA, Fritsche LG, Keilhauer CN, Lichtner P, Meitinger T, Weber BH. Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk. Hum Mol Genet. 2005;14(21):3227–36. doi:10.1093/hmg/ddi353.
  • Atan D, Fraser-Bell S, Plskova J, Kuffova L, Hogan A, Tufail A, Kilmartin DJ, Forrester JV, Bidwell JL, Dick AD, et al. Punctate inner choroidopathy and multifocal choroiditis with panuveitis share haplotypic associations with IL10 and TNF loci. Invest Ophthalmol Vis Sci. 2011;52(6):3573–81. doi:10.1167/iovs.10-6743.
  • Chen Y, Zeng J, Zhao C, Wang K, Trood E, Buehler J, Weed M, Kasuga D, Bernstein PS, Hughes G, et al. Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors. Arch Ophthalmol. 2011;129(3):344–51. doi:10.1001/archophthalmol.2011.10.
  • Leveziel N, Yu Y, Reynolds R, Tai A, Meng W, Caillaux V, Calvas P, Rosner B, Malecaze F, Souied EH, et al. Genetic factors for choroidal neovascularization associated with high myopia. Invest Ophthalmol Vis Sci. 2012;53:5004. doi:10.1167/iovs.12-9538.
  • Sharma NK, Gupta A, Prabhakar S, Singh R, Bhatt AK, Anand A. CC chemokine receptor-3 as new target for age-related macular degeneration. Gene. 2013;523(1):106–11. doi:10.1016/j.gene.2013.03.052.
  • Hagstrom SA, Ying GS, Maguire MG, Martin DF, Gibson J, Lotery A, Chakravarthy U. VEGFR2 gene polymorphisms and response to anti-vascular endothelial growth factor therapy in age-related macular degeneration. Ophthalmology. 2015;122(8):1563–68. doi:10.1016/j.ophtha.2015.04.024.
  • Huang L, Meng Q, Zhang C, Sun Y, Bai Y, Li S, Deng X, Wang B, Yu W, Zhao M, et al. Gene-gene interaction of CFH, ARMS2, and ARMS2/HTRA1 on the risk of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in Chinese population. Eye (Lond). 2015;29(5):691–98. doi:10.1038/eye.2015.32.
  • Tamura Y, Konomi H, Sawada H, Takashima S, Nakajima A. Tissue distribution of type VIII collagen in human adult and fetal eyes. Invest Ophthalmol Vis Sci. 1991;32(9):2636–44.
  • Ikuno Y, Sayanagi K, Soga K, Sawa M, Gomi F, Tsujikawa M, Tano Y. Lacquer crack formation and choroidal neovascularization in pathologic myopia. Retina. 2008;28(8):1124–31. doi:10.1097/IAE.0b013e318174417a.
  • Yu Y, Bhangale TR, Fagerness J, Ripke S, Thorleifsson G, Tan PL, Souied EH, Richardson AJ, Merriam JE, Buitendijk GH, et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration. Hum Mol Genet. 2011;20(18):3699–709. doi:10.1093/hmg/ddr270.
  • Fritsche LG, Chen W, Schu M, Yaspan BL, Yu Y, Thorleifsson G, Zack DJ, Arakawa S, Cipriani V, Ripke S, et al. Seven new loci associated with age-related macular degeneration. Nat Genet. 2013;45(4):433–39. 439e1–2. doi:10.1038/ng.2578.
  • Seddon JM, Reynolds R, Yu Y, Rosner B. Three new genetic loci (R1210C in CFH, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration. PLoS One. 2014;9(1):e87047. doi:10.1371/journal.pone.0087047.
  • Seddon JM, Silver RE, Kwong M, Rosner B. Risk prediction for progression of macular degeneration: 10 common and rare genetic variants, demographic, environmental, and macular covariates. Invest Ophthalmol Vis Sci. 2015;56(4):2192–202. doi:10.1167/iovs.14-15841.
  • Velazquez-Villoria A, Recalde S, Anter J, Bezunartea J, Hernandez-Sanchez M, García-García L, Alonso E, Ruiz-Moreno JM, Araiz-Iribarren J, Fernandez-Robredo P, et al. Evaluation of 10 AMD associated polymorphisms as a cause of choroidal neovascularization in highly myopic eyes. PLoS One. 2016;11(9):e0162296. doi:10.1371/journal.pone.0162296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.